Status | Study |
Recruiting |
Study Name: Assessment of Minimal Residual Disease (MRD) After Antineoplastic Treatment in Patients With AL Amyloidosis Condition: Amyloidosis Date: 2016-03-14 Interventions: Other: blood collection Other: bone marrow |
Active, not recruiting |
Study Name: The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis Condition: AL Amyloidosis Date: 2015-12-09 Interventions: Drug: NEOD001 NEOD001 is a mon |
Active, not recruiting |
Study Name: Open-label Extension Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis Condition: AL Amyloidosis Date: 2015-11-18 Interventions: Drug: NEOD001 NEOD001 |
Active, not recruiting |
Study Name: Quality of Life (QOL) Registry for Patients With AL Amyloidosis Condition: AL Amyloidosis Amyloidosis Date: 2015-10-05 Interventions: Other: non-interventional |
Recruiting |
Study Name: Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL Amyloidosis Condition: Amyloidosis Primary Amyloidosis Date: 2015-09-16 |
Terminated |
Study Name: Idelalisib for Immunoglobulin M (IgM)-Associated Primary (AL) Amyloidosis Condition: Amyloidosis Date: 2015-09-09 Interventions: Drug: Idelalisib Idelalisib daily until unacceptable toxicity or disease progression. |
Not yet recruiting |
Study Name: A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis Condition: Amyloidosis Date: 2015-08-27 Interventions: Drug: Carfilzomib Lyophilized |
Suspended |
Study Name: Trial of HDM/SCT Versus HDM + Bortezomib/SCT in AL Amyloidosis Condition: AL Amyloidosis Date: 2015-03-09 Interventions: Drug: Bortezomib |
Recruiting |
Study Name: The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis Condition: Primary Systemic (AL) Amyloidosis Date: 2014-12-02 Interventions: Drug: NEOD001 NEOD001, is a hu |
Completed |
Study Name: Allo SCT in Amyloidosis Non-interventional Study Condition: AL Amyloidosis Date: 2014-10-02 |